Nuvectis Pharma, Inc. NVCT Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$6.05M+17.3% | -$7.31M+2.0% | -$7.46M-17.8% | -$6.33M-18.8% | -$5.33M+14.7% | ||
| $1.85M+25.3% | $1.48M+1.3% | $1.46M-15.8% | $1.73M+26.5% | $1.37M+19.9% | ||
| -$1.58M— | $0-100% | $1.46M-26.3% | $1.99M+302% | $494K— | ||
| -$79K— | —— | —— | -$863K-3,552% | $25K-95.5% | ||
| $193K— | —— | —— | —— | $210K— | ||
| -$6.51M-63.8% | -$3.97M+11.6% | -$4.49M-33.5% | -$3.37M+19.3% | -$4.17M-69.3% | ||
| $0— | —— | —— | —— | $0— | ||
| —— | —— | —— | —— | —— | ||
| $7K-95.8% | $166K-98.7% | $13.14M+4,340% | $296K-98.1% | $15.51M+305% | ||
| -$6.5M— | —— | $8.65M— | —— | $11.33M— | ||
| -$460K-124% | $1.91M+2,400% | -$83K-289% | $44K+108% | -$519K-129% | ||
| $193K— | —— | —— | —— | $210K— | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | $300K— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Nuvectis Pharma, Inc. generate?
- Nuvectis Pharma, Inc. (NVCT) generated -$18.3M in operating cash flow over the trailing twelve months.
- Where does Nuvectis Pharma, Inc.'s cash flow data come from?
- Every line is extracted from Nuvectis Pharma, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.